Neue Suche | Kongressdetail
mail
Druckansicht
 
 

3rd ALS Drug Development Summit 2024

Evvnt Promotion / evvnt
-
21.05.2024 - 23.05.2024  Hyatt Regency Boston, 1 Avenue de Lafayette, 02111 Boston, Massachusetts, USA
Time: 8:00 AM - 5:00 PM
 
Kongressthemen
Identify Transformative ALS Targets, Seek Translational Biomarkers and Propel More Clinical Approvals

Following monumental progress in 2023, the ALS treatment landscape is surging with novel innovation to navigate the complex, multifactorial nature of motor neuron degeneration and develop more truly transformative drugs for sporadic and familial ALS.
Kongressorganizer (PCO)
Hanson Wade
Anmerkungen
URL:
Brochure: https://go.evvnt.com/2215799-3?pid=4832

Speakers: Diego Cadavid Chief Medical Officer Verge Genomics, Disha Sood Senior Scientist Sanofi , Emily Caporello Director, Small Business Program NINDS/NIH , and more
 

Anfragen und Anmeldung:

https://go.evvnt.com/2215799-2?pid=4832
Frau Erin Thomas
 
Kategorien
Allgemeinmedizin
Sprache
Englisch
Kongressgebühr
Industry Pricing - Conference + Workshop Day: USD 3597.00, Industry Pricing - Conference Only: USD 2599.00, Service Provider Pricing - Conference + Workshop Day: USD 5197.00, Service Provider Pricing - Conference Only: USD 3699.00
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
 
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."

Hilfswerk AustriaCharité International AcademyHelix - Forschung & Beratung WienSwiss Tropical and Public Health InstituteAlumni Club Medizinische Universität WienÄrzte der WeltCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioEuropean Health Forum Gastein